ZoomInfo Technologies Inc GTM 深 沪
等待开盘 02-05 09:30:00 美东时间
6.87
-0.050
-0.72%
华盛通- 最 高7.18
- 今 开6.83
- 成交量 1135.50万股
- 最 低 6.67
- 昨 收 6.92
- 总市值 21.43亿
- 52周最高 12.63
- 市盈率 静 85.55
- 换手率 3.64%
- 52周最低 6.67
- 委 比 44.02%
- 总股本 3.12亿
- 历史最高 79.17
- 量 比 1.32
- 振 幅 7.37%
- 历史最低 6.67
- 每 手 1
- 风险率 0.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
3 Analysts Have This To Say About ZoomInfo Technologies
3 analysts have shared their evaluations of ZoomInfo Technologies (NASDAQ:GTM) ...
02-04 02:01
Piper Sandler Maintains Neutral on ZoomInfo Technologies, Lowers Price Target to $9
Piper Sandler analyst Hannah Rudoff maintains ZoomInfo Technologies (NASDAQ:GTM) with a Neutral and lowers the price target from $12 to $9.
02-03 19:09
Russell 2000 Extends Record Run, Electricity Stocks Swing: What's Moving Markets Friday?
Small caps continued their upward march, with the Russell 2000 notching a fresh all-time high for the eleventh consecutive session and outperforming the S&P 500 for eleven straight days—the longest such streak since 2008.<
01-17 02:15
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Barclays Maintains Equal-Weight on ZoomInfo Technologies, Lowers Price Target to $12
Barclays analyst Raimo Lenschow maintains ZoomInfo Technologies (NASDAQ:GTM) with a Equal-Weight and lowers the price target from $14 to $12.
01-13 04:20
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
BTIG Initiates Coverage On ZoomInfo Technologies with Buy Rating, Announces Price Target of $13
BTIG analyst Allan Verkhovski initiates coverage on ZoomInfo Technologies (NASDAQ:GTM) with a Buy rating and announces Price Target of $13.
2025-12-17 20:06
Keybanc Upgrades ZoomInfo Technologies to Sector Weight
Keybanc analyst Jackson Ader upgrades ZoomInfo Technologies (NASDAQ:GTM) from Underweight to Sector Weight.
2025-12-15 18:49
美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
2025-11-05 10:35
